Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 203231
Company: INFORLIFE
Company: INFORLIFE
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
ZOLEDRONIC ACID | ZOLEDRONIC ACID | EQ 4MG BASE/100ML | INJECTABLE;INTRAVENOUS | Prescription | AP | Yes | Yes |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
08/02/2013 | ORIG-1 | Approval | Type 5 - New Formulation or New Manufacturer | STANDARD |
Label (PDF)
Letter (PDF) Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203231s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/203231Orig1s000TAltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/203231Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/203231Orig1s000TOC.cfm |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
04/05/2022 | SUPPL-19 | Labeling-Container/Carton Labels, Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203231Orig1s019Lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/203231Orig1s019ltr.pdf | |
10/27/2020 | SUPPL-17 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203231s015s016s017lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/203231Orig1s015,s016,s017ltr.pdf | |
10/27/2020 | SUPPL-16 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203231s015s016s017lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/203231Orig1s015,s016,s017ltr.pdf | |
10/27/2020 | SUPPL-15 | Labeling-Package Insert |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/203231Orig1s015,s016,s017ltr.pdf |
02/02/2017 | SUPPL-13 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203231s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/203231Orig1s013ltr.pdf | |
03/25/2016 | SUPPL-11 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/203231s011lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/203231Orig1s011ltr.pdf | |
10/08/2015 | SUPPL-10 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/203231s010lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/203231Orig1s010ltr.pdf | |
08/31/2015 | SUPPL-9 | Manufacturing (CMC) |
Label is not available on this site. |
||
08/31/2015 | SUPPL-8 | Manufacturing (CMC) |
Label is not available on this site. |
||
12/10/2014 | SUPPL-7 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203231s005s006s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/203231Orig1s005,s006,s007ltr.pdf | |
12/10/2014 | SUPPL-6 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203231s005s006s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/203231Orig1s005,s006,s007ltr.pdf | |
12/10/2014 | SUPPL-5 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203231s005s006s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/203231Orig1s005,s006,s007ltr.pdf | |
03/11/2014 | SUPPL-4 | Manufacturing (CMC) |
Label is not available on this site. |
||
05/02/2014 | SUPPL-2 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203231s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/203231Orig1s002ltr.pdf | |
02/07/2014 | SUPPL-1 | Manufacturing (CMC) |
Label is not available on this site. |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
04/05/2022 | SUPPL-19 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203231Orig1s019Lbl.pdf | |
04/05/2022 | SUPPL-19 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203231Orig1s019Lbl.pdf | |
10/27/2020 | SUPPL-17 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203231s015s016s017lbl.pdf | |
10/27/2020 | SUPPL-16 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203231s015s016s017lbl.pdf | |
02/02/2017 | SUPPL-13 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203231s013lbl.pdf | |
03/25/2016 | SUPPL-11 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/203231s011lbl.pdf | |
10/08/2015 | SUPPL-10 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/203231s010lbl.pdf | |
12/10/2014 | SUPPL-7 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203231s005s006s007lbl.pdf | |
12/10/2014 | SUPPL-6 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203231s005s006s007lbl.pdf | |
12/10/2014 | SUPPL-5 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203231s005s006s007lbl.pdf | |
05/02/2014 | SUPPL-2 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203231s002lbl.pdf | |
08/02/2013 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203231s000lbl.pdf |
ZOLEDRONIC ACID
INJECTABLE;INTRAVENOUS; EQ 4MG BASE/100ML
TE Code = AP
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
ZOLEDRONIC | ZOLEDRONIC ACID | EQ 4MG BASE/100ML | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 205749 | GLAND PHARMA LTD |
ZOLEDRONIC ACID | ZOLEDRONIC ACID | EQ 4MG BASE/100ML | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 210174 | AMNEAL |
ZOLEDRONIC ACID | ZOLEDRONIC ACID | EQ 4MG BASE/100ML | INJECTABLE;INTRAVENOUS | Prescription | Yes | AP | 203231 | INFORLIFE |